HALEON PLC-ADR (HLN) Stock Price, Quote, News and Summary
NYSE:HLN - New York Stock Exchange, Inc. - US4055521003 - ADR
HLN Quote and Key Statistics
HALEON PLC-ADR
NYSE:HLN (1/17/2025, 8:06:14 PM)
After market: 9.14 -0.1 (-1.08%)9.24
+0.05 (+0.54%)
HLN Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.66% | ||
| ROA | 3.26% | ||
| ROE | 6.55% | ||
| Debt/Equity | 0.45 |
HLN Performance and Technical Analysis
HLN Ownership and Analysts
HLN Latest News and Analysis
HLN Makes Notable Cross Below Critical Moving Average
TUMS Teams Up with DraftKings to Launch TUMS Fantasy Foodball Pool, Making Gameday Food Dreams a Reality
/PRNewswire/ -- As hundreds of millions prepare to tune into the biggest day in football, a new survey from TUMS has revealed that 1 in 4 viewers will be...
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS.
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?
Pfizer's 2025 guidance to be revealed Tuesday. Goldman Sachs predicts $64.9 billion revenue and EPS of $3.13, supported by Paxlovid and Eliquis growth.
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?
Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the call, Goldman Sachs has outlined its expectations for the guide and commentary on the upcoming year. The analyst anticipates that Pfizer’s management will guide to EPS in the mid-to-high $2 range with core business growth offset by the $0.30 in favorable but non-recurring items during 2024. Pfizer highlighted several factors affecting its 2024 EPS that won’t carry over to 20
Haleon Welcomes Joe Sta-Romana as Chief Customer Officer to Lead US Growth and Transformation
/PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for...
About HLN
Company Profile
Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The firm's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The firm's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Company Info
HALEON PLC-ADR
Building 5, First Floor, The Heights
Weybridge SURREY GB
Employees: 25408
Company Website: https://www.haleon.com/
Investor Relations: https://www.haleon.com/investors
Phone: 441932822000
HLN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 20.24 | 137.66B | ||
| KVUE | KENVUE INC | 17.73 | 40.45B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 29.6 | 27.95B | ||
| BRBR | BELLRING BRANDS INC | 37.51 | 9.34B | ||
| ELF | ELF BEAUTY INC | 40.43 | 7.15B | ||
| COTY | COTY INC-CL A | 17 | 6.21B | ||
| IPAR | INTERPARFUMS INC | 29.74 | 4.44B | ||
| ODD | ODDITY TECH LTD-CL A | 23.37 | 2.56B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 11.02 | 1.64B | ||
| OLPX | OLAPLEX HOLDINGS INC | 12.15 | 1.05B | ||
| HNST | HONEST CO INC/THE | N/A | 664.32M | ||
| HLF | HERBALIFE LTD | 3.49 | 662.19M |